These results consistently supported that celastrol might ameliorate the pathological alterations in NAFLD mice through inhibiting Warburg effect and skewing macrophage M1/M2 polarization through targeting PKM2. The gene discussed is PKM; the disease is metabolic dysfunction-associated steatotic liver disease.